| [1] |
ZHU Lei, HAO Dandan.
Research progress on non-coding RNAs in the regulation of ferroptosis mediated sorafenib resistance in hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2025, 39(3): 256-261.
|
| [2] |
ZHANG Beining, WANG Jiangye, MA Kewen, SUN Guoliang, YAN Kesong, ZHENG Ninggang.
Expression and mechanism of miRNA in the occurrence and development of hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2025, 39(1): 61-66.
|
| [3] |
FAN Yunyuan, TANG Xian, WEN Hongmei, SHAO Ying, SHI Jingyin, ZHANG Shuangquan.
Analysis of the incidence and mortality of liver cancer in cancer registration areas of Yunnan province in 2020 and the trend from 2012 to 2020
[J]. Journal of Practical Oncology, 2024, 38(6): 377-382.
|
| [4] |
ZHANG Kangjun, FANG Taishi, CEN Fulan, YAN Xu, CHEN Qijun, MA Nan.
circ_0008043 promotes glycolysis of hepatocellular carcinoma and the development of hepatocellular carcinoma through miR-198/SLC2A1 axis
[J]. Journal of Practical Oncology, 2024, 38(6): 388-401.
|
| [5] |
YANG Xiaobin, WANG Junping.
Effects of BTg-3 on proliferation,invasion,migration and Akt/GSK-3β/β-catenin signaling pathway of liver cancer cells
[J]. Journal of Practical Oncology, 2024, 38(6): 410-416.
|
| [6] |
GUAN Yongyu, NIE Hao, ZHANG Chong.
Research progress of hepatocellular carcinoma mouse models
[J]. Journal of Practical Oncology, 2024, 38(5): 342-348.
|
| [7] |
HOU Mingxing, WEI Yonggang.
A Meta-analysis of the clinical efficacy of hepatic arterial chemoembolization combined with second-stage surgical resection and hepatic arterial chemoembolization alone for unresectable intermediate and advanced liver cancer in Chinese population
[J]. Journal of Practical Oncology, 2024, 38(2): 112-120.
|
| [8] |
WU Dongyang, CAI Qingshan, LIU Dong, ZUO Ganggang, LI Shudong, LIU Liyou, ZHENG Jianxing.
The effects and mechanism of long non-coding RNA CASC15 on proliferation,invasion and migration of hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2024, 38(1): 18-29.
|
| [9] |
DENG Jielian, ZHENG Wei, LI Kangjie, ZHANG Cong, ZHANG Yuan, XIE Biao, ZHONG Xiaoni.
Construction of a prognostic risk prediction model in liver cancer for macrophage related genes based on single-cell RNA-seq and bulk RNA-seq data
[J]. Journal of Practical Oncology, 2023, 37(5): 403-410.
|
| [10] |
PANG Wu, CHEN Lijiang, ZHU Yu, WU Yakun, ZHANG Wei.
The expression of serum miRNA-24 and miRNA-509 in patients with hepatocellular carcinoma and their correlation with prognosis
[J]. Journal of Practical Oncology, 2023, 37(5): 411-415.
|
| [11] |
WANG Congju, WANG Mengru, XU Yuwen, SUN Hongpeng, MA Qinghua, HUANG Lan.
Analysis of the high-risk rate of liver cancer and diet-related influencing factors in Suzhou city
[J]. Journal of Practical Oncology, 2023, 37(4): 308-312.
|
| [12] |
CUI Yongkang, YU Chengping, XU Haozhi, MA Xinyu, MA Yong, LI Linqiang.
Effects of nutritional risk index in predicting postoperative complications and prognosis of patients with resectable hepatocellular carcinoma
[J]. Journal of Practical Oncology, 2023, 37(3): 243-251.
|
| [13] |
WANG Jiabei, ZHANG Yunguang, LIU Lianxin.
Clinical efficacy and safety analysis of immunotherapy combined with molecularly targeted drugs in the treatment of advanced hepatocellular carcinoma:A single-arm retrospective study
[J]. Journal of Practical Oncology, 2022, 36(6): 489-494.
|
| [14] |
SUN Xinglu, CHEN Che.
Research progress of Egr1 in liver cancer
[J]. Journal of Practical Oncology, 2022, 36(5): 435-439.
|
| [15] |
NA Jun, AN Xiaoxia, LI Xun, ZHANG Weiwei, MU Huijuan, LI Yanxia, PAN Guowei, LIU Li.
Analysis of 10-year survival rate of liver cancer among residents in three cities of Liaoning province from 2000 to 2002
[J]. Journal of Practical Oncology, 2022, 36(4): 293-298.
|
